R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
Digital Initial leap of faith inspires today’s fast-growing digital ... Explore how Tufts Center for the Study of Drug Development has spearheaded the growth of digital clinical trials through an initial leap of faith
Digital JP Morgan Week 2025 – Trân Lê and Sohit Gatiganti pharmaphorum sits down for a quick chat with the Grove.AI team about their new AI agent for clinical trial recruitment.
R&D Tech & Trials: Recruiting is hard, AI can make it easier Recruiting for clinical trials is hard… and expensive.
Patients How to advance diversity, equity and inclusion in clinical t... The principles of diversity, equity and inclusion (DEI) are now a commonplace expectation in our world, positively impacting everything, from workplaces to classrooms to hospital halls.
Patients 5 patient travel strategies to impact enrolment diversity in... According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.